Skip to content
Screener

Elevance Health ELV Q4 2024 Annual earnings

Reported January 23, 2025 · Before market open

Revenue$45.4BBeat by $489.5M
EPS$3.84Beat by $0.04
Revenue estimate$45.0B
EPS estimate$3.80

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$49.3B
EPS estimate$4.66

Financials

Q4 2024

Income statement

See full
Revenue$45.4B+6.6%
Gross profit$39.4B+4.3%
Net income$418.0M-51.2%
EPS (diluted)$1.87-48.9%

Balance sheet

See full
Cash & equivalents$8.3B+27.0%
Total debt$30.4B+25.0%
Total equity$41.3B+5.1%
Total assets$116.89B+7.3%

Cash flow

See full
Operating cash flow$706.0M—
CapEx$322.0M-1.2%
Free cash flow$384.0M—

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$85.56B-22.2%
Enterprise value$107.66B-15.7%
P/E14.3×-4.1×
P/S0.5×-0.2×

Profitability

See full
Gross margin88.8%-1.1pp
Net margin3.4%-0.1pp
FCF margin2.6%—

Returns & leverage

See full
Return on equity14.8%-1.0pp
Debt / equity0.7×+0.1×
Current ratio1.5×0.0×

Segments

By product

See full
Service fees$2.0B+5.6%

FAQ

When did Elevance Health report Q4 2024 earnings?
Elevance Health (ELV) reported Q4 2024 earnings on January 23, 2025 before market open.
What were Elevance Health's Q4 2024 revenue and EPS?
Elevance Health reported revenue of $45.4B and eps of $3.84 for Q4 2024.
Did Elevance Health beat estimates in Q4 2024?
Revenue beat the consensus estimate of $45.0B by $489.5M. EPS beat the consensus estimate of $3.80 by $0.04.
Where can I find Elevance Health's Q4 2024 SEC filings?
You can read the 8-K earnings release (0001156039-25-000007) and the 10-K periodic report (0001156039-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.